BR112021015481A2 - Otimização biotecnológica de micro-organismos para a 1,2-desidrogenação de esteroides - Google Patents

Otimização biotecnológica de micro-organismos para a 1,2-desidrogenação de esteroides

Info

Publication number
BR112021015481A2
BR112021015481A2 BR112021015481A BR112021015481A BR112021015481A2 BR 112021015481 A2 BR112021015481 A2 BR 112021015481A2 BR 112021015481 A BR112021015481 A BR 112021015481A BR 112021015481 A BR112021015481 A BR 112021015481A BR 112021015481 A2 BR112021015481 A2 BR 112021015481A2
Authority
BR
Brazil
Prior art keywords
dehydrogenation
steroids
biotechnological
microorganisms
optimization
Prior art date
Application number
BR112021015481A
Other languages
English (en)
Portuguese (pt)
Inventor
Bernd Janocha
Tobias LATTEMANN Claus
Hans-Falk Rasser
Sebastian Rissom
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of BR112021015481A2 publication Critical patent/BR112021015481A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/02Dehydrogenating; Dehydroxylating
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/001Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/010533-Alpha (or 20-beta)-hydroxysteroid dehydrogenase (1.1.1.53)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y103/00Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/99Oxidoreductases acting on the CH-CH group of donors (1.3) with other acceptors (1.3.99)
    • C12Y103/990043-Oxosteroid 1-dehydrogenase (1.3.99.4)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365Nocardia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
BR112021015481A 2019-02-08 2020-02-07 Otimização biotecnológica de micro-organismos para a 1,2-desidrogenação de esteroides BR112021015481A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19305153 2019-02-08
PCT/EP2020/053167 WO2020161317A1 (en) 2019-02-08 2020-02-07 Biotechnological optimization of microorganisms for the 1,2-dehydrogenation of steroids

Publications (1)

Publication Number Publication Date
BR112021015481A2 true BR112021015481A2 (pt) 2021-12-07

Family

ID=66554300

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021015481A BR112021015481A2 (pt) 2019-02-08 2020-02-07 Otimização biotecnológica de micro-organismos para a 1,2-desidrogenação de esteroides

Country Status (14)

Country Link
US (1) US20220136029A1 (https=)
EP (1) EP3921414A1 (https=)
JP (2) JP7661229B2 (https=)
KR (1) KR20210125490A (https=)
CN (1) CN113423827A (https=)
AU (1) AU2020219424A1 (https=)
BR (1) BR112021015481A2 (https=)
CA (1) CA3128954A1 (https=)
IL (1) IL285386A (https=)
MX (1) MX2021009515A (https=)
SG (1) SG11202108529WA (https=)
TW (1) TWI852986B (https=)
WO (1) WO2020161317A1 (https=)
ZA (1) ZA202105566B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202108529WA (en) * 2019-02-08 2021-09-29 Sanofi Sa Biotechnological optimization of microorganisms for the 1,2-dehydrogenation of steroids
CN118325997B (zh) * 2024-04-10 2025-07-22 湖南玉新药业有限公司 采用诺卡氏菌一步发酵生产泼尼松龙的方法
CN119464157B (zh) * 2025-01-13 2025-06-27 山东绿邦生物科技有限公司 居瘤胃棒状杆菌、微生物菌剂及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1232278A1 (en) * 1999-10-22 2002-08-21 Akzo Nobel N.V. MICROBIAL 9$g(a)-HYDROXYLATION OF STEROIDS
JP2007515490A (ja) * 2003-12-22 2007-06-14 アムジェン インコーポレーティッド アリールスルホンアミド化合物およびそれに関連する使用法
US20050239853A1 (en) * 2004-02-04 2005-10-27 Tjeerd Barf New compounds
WO2006124141A2 (en) * 2005-04-05 2006-11-23 Taro Pharmaceuticals North America, Inc. A process of preparing prednisolone devoid of steroid-derived impurities using recombinant e. coli transformed with a δ1-dehydrogenase gene
AU2013200516B2 (en) * 2006-07-12 2015-09-03 University Of Tennessee Research Foundation Substituted Acylanilides and Methods of Use Thereof
DK2084519T3 (da) * 2006-10-10 2012-08-20 Los Alamos Nat Security Llc Røntgenfluorescens-analysefremgangsmåde
CN106754775B (zh) * 2016-12-23 2019-08-20 华东理工大学 一种羰基还原酶突变体及其基因与应用
WO2018204764A1 (en) * 2017-05-05 2018-11-08 Camp4 Therapeutics Corporation Identification and targeted modulation of gene signaling networks
AU2019384074B2 (en) * 2018-11-20 2025-04-10 Sparrow Pharmaceuticals, Inc. Methods for administering corticosteroids
SG11202108529WA (en) * 2019-02-08 2021-09-29 Sanofi Sa Biotechnological optimization of microorganisms for the 1,2-dehydrogenation of steroids

Also Published As

Publication number Publication date
JP2025038080A (ja) 2025-03-18
US20220136029A1 (en) 2022-05-05
TW202045720A (zh) 2020-12-16
KR20210125490A (ko) 2021-10-18
ZA202105566B (en) 2024-05-30
JP2022519711A (ja) 2022-03-24
AU2020219424A1 (en) 2021-08-26
TWI852986B (zh) 2024-08-21
SG11202108529WA (en) 2021-09-29
MX2021009515A (es) 2021-10-26
CA3128954A1 (en) 2020-08-13
IL285386A (en) 2021-09-30
CN113423827A (zh) 2021-09-21
EP3921414A1 (en) 2021-12-15
WO2020161317A1 (en) 2020-08-13
JP7661229B2 (ja) 2025-04-14

Similar Documents

Publication Publication Date Title
MX2021000308A (es) Composiciones de fusosoma y usos de estas.
MX2020012295A (es) Composiciones de fusosoma y usos de estas.
BR112021015481A2 (pt) Otimização biotecnológica de micro-organismos para a 1,2-desidrogenação de esteroides
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
EP3814303A4 (en) NEW PLANT NUTRITION AND STRENGTH COMPOSITION
MX376284B (es) Una composición que comprende un agente antibiótico y un agente dispersante o un agente antiadhesivo.
MA52981A (fr) Nouvelle composition nutritionnelle et fortifiante de culture
BR112016016889A2 (pt) Acionamento de uma mão destinada a ser utilizada em um robô humanoide
BR112018000768A2 (pt) anticorpos anti-pd-1, anticorpos anti-pd-1 ativáveis e métodos de uso dos mesmos
MA52637A (fr) Compositions de lutte contre les agents pathogènes et leurs utilisations
GB201014033D0 (en) Biological products
BR112018001441A2 (pt) antibacterianos terapêuticos e profiláticos
CL2015003415A1 (es) Panel de construcción que tiene una fuerza de fijación mejorada y método para la elaboración del mismo.
JOP20230239A1 (ar) أجسام مضادة للنكتين-4 واستخدامتها
BR112017023238A2 (pt) artigo e método de formação de um artigo
BR112015003478A2 (pt) ferramenta de mão, em particular, uma pistola para solda
BR112017023636A2 (pt) suplemento dietético
BR112016017509A2 (pt) composições e métodos compreendendo uma variante da enzima xilanase
MX356959B (es) Cepa paenibacillus alvei ts-15 y su uso en el control de organismos patogenicos.
BR112022002942A2 (pt) Composição enzimática
MA55590A (fr) Gène 1 induit par l'interleukine 4 (il4i1) en tant que biomarqueur et ses utilisations
MA38526B1 (fr) Nouvelle souche bactérienne de lysobacter capsici et ses utilisations
BR112016025999A2 (pt) micro-organismo tendo produtividade de l-lisina aperfeiçoada e método para produção de l-lisina usando o mesmo
MY207387A (en) Methods for the production of methacrylates
BR112017004246A2 (pt) mancal simples ou parte do mesmo, método para a sua produção e uso de uma liga de cucrzr como um material de mancal simples

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: SANOFI (FR)

B25A Requested transfer of rights approved

Owner name: EUROAPI FRANCE (FR)